Alpha Tau Medical: 2026 Is The Breakthrough Year

Alpha DaRT alpha-particle therapy, key 2026 trial catalysts, cash/dilution risks, and M&A takeover potential. See more.
Nature

Alpha Particle Radioluminescence Detection and Imaging

Alpha particle radioluminescence detection and imaging is an advanced optical technique that capitalises on the light emitted when alpha particles interact with air molecules. When alpha particles – ...
EDN

K&S says new lead-free alloy reduces alpha emissions in flip-chip packages

WILLOW GROVE, Pa. — Kulicke & Soffa Industries Inc. today said tests have demonstrated extremely low-level alpha particle emissions in a new ultra-pure, lead-free alloy developed for flip-chip ...
Seeking Alpha

Perspective Therapeutics: Giving Us Some Valuable Perspective On Alpha Emitter Therapy

Perspective Therapeutics' pipeline, led by VMT-a-NET, shows promising safety and early efficacy, but lacks clear superiority over existing therapies like Lutathera so far. The company maintains a ...

Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased

Alpha Tau Medical (NASDAQ:DRTS) provided investors with a series of clinical, regulatory and financial updates, highlighting ...
EDN

Equipment refines soft-error detection in chips

AUSTIN, Texas — The detection of soft errors in silicon chips is attracting attention on several fronts, as the struggle intensifies to prevent glitches caused by the naturally occurring bombardment ...